Recruitment of IFN-γ-Producing (Th1-Like) Cells into the Inflamed Retina In Vivo Is Preferentially Regulated by P-Selectin Glycoprotein Ligand 1:P/E-Selectin Interactions-Reference-Cited by-同舟云学术

Recruitment of IFN-γ-Producing (Th1-Like) Cells into the Inflamed Retina In Vivo Is Preferentially Regulated by P-Selectin Glycoprotein Ligand 1:P/E-Selectin Interactions

Published:2004-02-20 Issue:5 Volume:172 Page:3215-3224
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Xu Heping,Manivannan Ayyakkannu,Jiang Hui-Rong,Liversidge Janet,Sharp Peter F.,Forrester John V.,Crane Isabel J.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference77 articles.

1. TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties

2. Functional diversity of helper T lymphocytes

3. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.

4. Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis

5. Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vascular Cell Adhesion Molecule-1 (VCAM-1) contributes to macular fibrosis in neovascular age-related macular degeneration through modulating macrophage functions;Immunity & Ageing;2023-11-20

2. PSGL-1, a Strategic Biomarker for Pathological Conditions in HIV Infection: A Hypothesis Review;Viruses;2023-10-31

3. Pre-Activated Granulocytes from an Autoimmune Uveitis Model Show Divergent Pathway Activation Profiles upon IL8 Stimulation In Vitro;International Journal of Molecular Sciences;2022-08-23

4. Adhesion Molecule Targeted Therapy for Non-Infectious Uveitis;International Journal of Molecular Sciences;2022-01-03

5. P-Selectin Glycoprotein Ligand 1: A Potential HIV-1 Therapeutic Target;Frontiers in Immunology;2021-08-09